NASDAQ : RKDA

Arcadia Biosciences, Inc.

$0.64 USD

$0.02 (2.89%)

Volume
5.32K
Average Volume
3.09M
Market Capitalization
$990.28K
P/E Ratio
-0.09
Dividend Yield
0.00%
Price Target
$6.00
Year High
$6.71
Year Low
$0.59
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$3.79
Company Overview

NASDAQ

Thomas J. Schaefer

Agricultural Inputs

Basic Materials

RKDA

8

US

USD

530 756 7077

039014303

0001469443

Liquidity Metrics

0.00

3.79

3.17

0.70

0.00

Sales & Valuation

$4.86M

0.21

0.30

-0.23

-3.11

Profitability

-$1.71

-$2.34M

-195.94%

-195.78%

-219.35%

-175.15%

P/E Metrics

-0.09

0.00

0.00

Analyst Price Target & Rating

$6.00

$6.00

$6.00

Strong Sell

1/5

5 Analysts

-89.33%

Financial Health Scores

-78.90

2/9

$3.8M

$5.32M

$2.44M

-$9.32M

Key Metrics (TTM)

$36283.0

0.01

0.00

3.79

-219.35%

-241.36%

-1064.81%

-429.17%

2 days

Company Executives
Name Title
Thomas J. Schaefer CEO, Interim CFO, Principal Accounting Officer, President, Corporate Secretary & Director
Poll Results

No votes yet today — be the first to share your view!

About Arcadia Biosciences, Inc. (NASDAQ:RKDA) Stock

Arcadia Biosciences, Inc. is a U.S.-based company that provides plant-derived health and well-being products. Additionally, it is actively engaged in agricultural research and development, with a particular focus on improving wheat crops. The aim of these innovations is to enhance farmers' economic stability by boosting crop performance in the field, increasing their value for food and wellness applications, and expanding their potential for industrial uses. Established in 2002, the company's main office is located in Davis, California. ...

Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

2026-06-12 22:00:00

DALLAS, June 12, 2026 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc. (Nasdaq: RKDA), a producer and marketer of innovative wellness products, announced today the closing of its previously announced private placement priced at-the-market under Nasdaq rules for the purchase and sale of 3,883,496 shares of its common stock (or pre-funded warrants in lieu thereof), Series A-1 preferred investment options to purchase up to an aggregate of 3,883,496 shares of common stock and Series A-2 preferred investment options to purchase up to an aggregate of 3,883,496 shares of common stock at a purchase price of $1.

Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

2026-06-12 22:00:00

DALLAS, June 12, 2026 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative wellness products, announced today the closing of its previously announced private placement priced at-the-market under Nasdaq rules for the purchase and sale of 3,883,496 shares of its common stock (or pre-funded warrants in lieu thereof), Series A-1 preferred investment options to purchase up to an aggregate of 3,883,496 shares of common stock and Series A-2 preferred investment options to purchase up to an aggregate of 3,883,496 shares of common stock at a purchase price of $1.03 per share of common stock (or pre-funded warrant in lieu thereof) and associated preferred investment options.

Arcadia Biosciences (RKDA) Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

2026-06-11 20:00:00

DALLAS, June 11, 2026 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc. (Nasdaq: RKDA), a producer and marketer of innovative wellness products, announced today that it has entered into securities purchase agreements for the purchase and sale of 3,883,496 shares of its common stock (or pre-funded warrants in lieu thereof), Series A-1 preferred investment options to purchase up to an aggregate of 3,883,496 shares of common stock and Series A-2 preferred investment options to purchase up to an aggregate of 3,883,496 shares of common stock at a purchase price of $1.

Arcadia Biosciences (RKDA) Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

2026-06-11 20:00:00

DALLAS, June 11, 2026 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc .® (Nasdaq: RKDA), a producer and marketer of innovative wellness products, announced today that it has entered into securities purchase agreements for the purchase and sale of 3,883,496 shares of its common stock (or pre-funded warrants in lieu thereof), Series A-1 preferred investment options to purchase up to an aggregate of 3,883,496 shares of common stock and Series A-2 preferred investment options to purchase up to an aggregate of 3,883,496 shares of common stock at a purchase price of $1.03 per share of common stock (or pre-funded warrant in lieu thereof) and associated preferred investment options in a private placement priced at-the-market under Nasdaq rules.

Arcadia Biosciences (RKDA) Announces First Quarter 2026 Financial Results and Business Highlights

2026-05-14 16:05:00

-- Zola ® volumes increase 18% year-over-year -- -- SG&A at lowest level in Arcadia's history -- DALLAS, May 14, 2026 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc .® (Nasdaq: RKDA), a producer and marketer of innovative wellness products, today released its financial and business results for the first quarter of 2026.

Frequently Asked Questions

What is the current Arcadia Biosciences, Inc. (RKDA) stock price?

Arcadia Biosciences, Inc.(NASDAQ:RKDA) stock price is $0.64 in the last trading session. During the trading session, RKDA stock reached the peak price of $6.71 while $0.59 was the lowest point it dropped to. The percentage change in RKDA stock occurred in the recent session was 2.89% while the dollar amount for the price change in RKDA stock was $0.02.

RKDA's industry and sector of operation?

The NASDAQ listed RKDA is part of Agricultural Inputs industry that operates in the broader Basic Materials sector.

Who are the executives of RKDA?

Thomas J. Schaefer | CEO, Interim CFO, Principal Accounting Officer, President, Corporate Secretary & Director
|
|
|
|

How many employees does RKDA have?

Number of RKDA employees currently stands at 8. RKDA operates from 5956 Sherry Lane, Davis, TX 75225, US.

Link for RKDA official website?

Official Website of RKDA is: https://www.arcadiabio.com

How do I contact RKDA?

RKDA could be contacted at phone #530 756 7077 and can also be accessed through its website. RKDA operates from 5956 Sherry Lane, Davis, TX 75225, US.

How many shares of RKDA are traded daily?

The average number of RKDA shares traded daily for last 3 months was 3.09M.

What is the market cap of RKDA currently?

The market value of RKDA currently stands at $990.28K with its latest stock price at $0.64